| Preoperative psychosocial risk factors for poor outcomes at 1 and 5 years after total knee replacement: A cohort study of 266 patients V Wylde, L Trela-Larsen, MR Whitehouse, AW Blom Acta orthopaedica 88 (5), 530-536, 2017 | 40 | 2017 |
| Body mass index, body dissatisfaction and adolescent smoking initiation LJ Howe, L Trela-Larsen, M Taylor, J Heron, MR Munafò, AE Taylor Drug and alcohol dependence 178, 143-149, 2017 | 20 | 2017 |
| Chlamydia screening, retesting and repeat diagnoses in Cornwall, UK 2003–2009 KME Turner, PJ Horner, L Trela-Larsen, M Sharp, M May Sexually transmitted infections 89 (1), 70-75, 2013 | 16 | 2013 |
| The association between cement type and the subsequent risk of revision surgery in primary total hip replacement: 199, 205 hips from the National Joint Registry for England … L Trela-Larsen, A Sayers, AW Blom, JCJ Webb, MR Whitehouse Acta orthopaedica 89 (1), 40-46, 2018 | 8 | 2018 |
| Estimating an individual’s probability of revision surgery after knee replacement: a comparison of modeling approaches using a national data set P Aram, L Trela-Larsen, A Sayers, AF Hills, AW Blom, EV McCloskey, ... American journal of epidemiology 187 (10), 2252-2262, 2018 | 6 | 2018 |
| HAPRAP: a haplotype-based iterative method for statistical fine mapping using GWAS summary statistics J Zheng, S Rodriguez, C Laurin, D Baird, L Trela-Larsen, ... Bioinformatics 33 (1), 79-86, 2017 | 6 | 2017 |
| Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group J Leahy, C Hickey, D McConnell, O Cassidy, L Trela-Larsen, M Barry, ... Value in Health, 2020 | 2 | 2020 |
| Estimating patient-specific mortality after joint replacement: algorithm development and validation using national audit datasets JM Wilkinson, L Trela-Larsen, C Bartz-Johannessen, A Sayers, P Aram, ... Osteoarthritis and Cartilage 27, S229, 2019 | 1 | 2019 |
| An evaluation of survival modelling approaches for personalised risk prediction after hip replacement for osteoarthritis P Aram, L Trela-Larsen, A Sayers, AF Hills, AW Blom, EV McCloskey, ... Osteoarthritis and Cartilage 26, S281, 2018 | 1 | 2018 |
| P5-S7. 07 Chlamydia screening in Cornwall: How often do young people get retested? K Turner, L Trela-Larsen, P Gates, M May, P Horner Sexually Transmitted Infections 87 (Suppl 1), A344-A345, 2011 | 1 | 2011 |
| Understanding the challenges and uncertainties of seroprevalence studies for SARS-CoV-2 D McConnell, C Hickey, N Bargary, L Trela-Larsen, C Walsh, M Barry, ... Preprints, 2020 | | 2020 |
| PMU52 The Reliability of Budget IMPACT Predictions for Drugs with Incremental Cost Effectiveness Ratios ABOVE the Irish Threshold C Kennedy, L McCullagh, R Adams, L Trela-Larsen, L Tilson, M Barry Value in Health 23, S612, 2020 | | 2020 |
| PMU65 Drugs with Incremental Cost Effectiveness Ratios ABOVE the Irish Threshold and Subsequent Price Negotiations C Kennedy, L McCullagh, R Adams, L Trela-Larsen, L Tilson, M Barry Value in Health 23, S613, 2020 | | 2020 |
| THEMED SECTION: COVID-19 CD Mullins, MF Drummond, S Ma, DD Kim, JT Cohen, PJ Neumann, ... | | 2020 |
| Personalized estimation of one-year mortality risk after elective hip or knee arthroplasty for osteoarthritis: JointCalc model development and validation using the National … L Trela-Larsen, G Kroken, C Bartz-Johannessen, A Sayers, P Aram, ... Bone & Joint Research 9 (11), 808-820, 2020 | | 2020 |
| PCN284 PRESCRIBING TRENDS ACROSS EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS IN NON-SMALL CELL LUNG CANCER IN IRELAND C Gorry, E Connolly, L Trela-Larsen, M Barry Value in Health 22, S491, 2019 | | 2019 |
| PCN498 REAL-WORLD EVIDENCE ON THE UTILISATION OF ABIRATERONE AND ENZALUTAMIDE IN IRELAND L Trela-Larsen, C Usher, L McCullagh, M Barry, C Walsh Value in Health 22, S534, 2019 | | 2019 |
| AN EVALUATION OF SURVIVAL MODELLING APPROACHES FOR PERSONALIZED RISK PREDICTION AFTER HIP ARTHROPLASTY FOR OSTEOARTHRITIS P Aram, L Trela-Larsen, A Sayers, AF Hills, AW Blom, EV McCloskey, ... Orthopaedic Proceedings 101 (SUPP_2), 27-27, 2019 | | 2019 |
| PCN244-REAL-WORLD EVIDENCE ON THE UTILISATION OF REGORAFENIB IN IRELAND L Trela-Larsen, C Usher, L McCullagh, C Walsh Value in Health 21, S55, 2018 | | 2018 |
| AN EVALUATION OF SURVIVAL MODELLING APPROACHES FOR PERSONALIZED RISK PREDICTION AFTER HIP ARTHROPLASTY FOR OSTEOARTHRITIS P Aram, L Trela-Larsen, A Sayers, AF Hills, AW Blom, EV McCloskey, ... Orthopaedic Proceedings 100 (SUPP_9), 31-31, 2018 | | 2018 |
